Li, S., Kong, Y., Si, L., Chi, Z., Cui, C., Sheng, X., & Guo, J. (2014). Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma. BioMed Central.
استشهاد بنمط شيكاغوLi, Siming, Yan Kong, Lu Si, Zhihong Chi, Chuanliang Cui, Xinan Sheng, و Jun Guo. Phosphorylation of MTOR and S6RP Predicts the Efficacy of Everolimus in Patients With Metastatic Renal Cell Carcinoma. BioMed Central, 2014.
MLA استشهادLi, Siming, et al. Phosphorylation of MTOR and S6RP Predicts the Efficacy of Everolimus in Patients With Metastatic Renal Cell Carcinoma. BioMed Central, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.